HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor Suppression

Nikita Patel, Juehong Wang, Kumiko Shiozawa, Kevin B. Jones, Yanfeng Zhang, Jeremy W. Prokop, George G. Davenport, Naoe T. Nihira, Zhenyue Hao, Derek Wong, Laurel Brandsmeier, Sarah K. Meadows, Arthur V. Sampaio, Ryan Vander Werff, Makoto Endo, Mario R. Capecchi, Kelly M. McNagny, Tak W. Mak, Torsten O. Nielsen, T. Michael UnderhillRichard M. Myers, Tadashi Kondo, Le Su

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Histone deacetylases (HDACs)are promising targets for cancer therapy, although their individual actions remain incompletely understood. Here, we identify a role for HDAC2 in the regulation of MDM2 acetylation at previously uncharacterized lysines. Upon inactivation of HDAC2, this acetylation creates a structural signal in the lysine-rich domain of MDM2 to prevent the recognition and degradation of its downstream substrate, MCL-1 ubiquitin ligase E3 (MULE). This mechanism further reveals a therapeutic connection between the MULE ubiquitin ligase function and tumor suppression. Specifically, we show that HDAC inhibitor treatment promotes the accumulation of MULE, which diminishes the t(X; 18)translocation-associated synovial sarcomagenesis by directly targeting the fusion product SS18-SSX for degradation. These results uncover a new HDAC2-dependent pathway that integrates reversible acetylation signaling to the anticancer ubiquitin response.

Original languageEnglish
Pages (from-to)43-54
Number of pages12
JournaliScience
Volume13
DOIs
Publication statusPublished - Mar 29 2019

Fingerprint

Ubiquitin-Protein Ligases
Ubiquitination
Acetylation
Histone Deacetylases
Lysine
Neoplasms
Ubiquitin
Therapeutics

All Science Journal Classification (ASJC) codes

  • General

Cite this

Patel, N., Wang, J., Shiozawa, K., Jones, K. B., Zhang, Y., Prokop, J. W., ... Su, L. (2019). HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor Suppression. iScience, 13, 43-54. https://doi.org/10.1016/j.isci.2019.02.008

HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor Suppression. / Patel, Nikita; Wang, Juehong; Shiozawa, Kumiko; Jones, Kevin B.; Zhang, Yanfeng; Prokop, Jeremy W.; Davenport, George G.; Nihira, Naoe T.; Hao, Zhenyue; Wong, Derek; Brandsmeier, Laurel; Meadows, Sarah K.; Sampaio, Arthur V.; Werff, Ryan Vander; Endo, Makoto; Capecchi, Mario R.; McNagny, Kelly M.; Mak, Tak W.; Nielsen, Torsten O.; Underhill, T. Michael; Myers, Richard M.; Kondo, Tadashi; Su, Le.

In: iScience, Vol. 13, 29.03.2019, p. 43-54.

Research output: Contribution to journalArticle

Patel, N, Wang, J, Shiozawa, K, Jones, KB, Zhang, Y, Prokop, JW, Davenport, GG, Nihira, NT, Hao, Z, Wong, D, Brandsmeier, L, Meadows, SK, Sampaio, AV, Werff, RV, Endo, M, Capecchi, MR, McNagny, KM, Mak, TW, Nielsen, TO, Underhill, TM, Myers, RM, Kondo, T & Su, L 2019, 'HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor Suppression', iScience, vol. 13, pp. 43-54. https://doi.org/10.1016/j.isci.2019.02.008
Patel, Nikita ; Wang, Juehong ; Shiozawa, Kumiko ; Jones, Kevin B. ; Zhang, Yanfeng ; Prokop, Jeremy W. ; Davenport, George G. ; Nihira, Naoe T. ; Hao, Zhenyue ; Wong, Derek ; Brandsmeier, Laurel ; Meadows, Sarah K. ; Sampaio, Arthur V. ; Werff, Ryan Vander ; Endo, Makoto ; Capecchi, Mario R. ; McNagny, Kelly M. ; Mak, Tak W. ; Nielsen, Torsten O. ; Underhill, T. Michael ; Myers, Richard M. ; Kondo, Tadashi ; Su, Le. / HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor Suppression. In: iScience. 2019 ; Vol. 13. pp. 43-54.
@article{a8ebf6889f97412fa1fd5a5937fe192e,
title = "HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor Suppression",
abstract = "Histone deacetylases (HDACs)are promising targets for cancer therapy, although their individual actions remain incompletely understood. Here, we identify a role for HDAC2 in the regulation of MDM2 acetylation at previously uncharacterized lysines. Upon inactivation of HDAC2, this acetylation creates a structural signal in the lysine-rich domain of MDM2 to prevent the recognition and degradation of its downstream substrate, MCL-1 ubiquitin ligase E3 (MULE). This mechanism further reveals a therapeutic connection between the MULE ubiquitin ligase function and tumor suppression. Specifically, we show that HDAC inhibitor treatment promotes the accumulation of MULE, which diminishes the t(X; 18)translocation-associated synovial sarcomagenesis by directly targeting the fusion product SS18-SSX for degradation. These results uncover a new HDAC2-dependent pathway that integrates reversible acetylation signaling to the anticancer ubiquitin response.",
author = "Nikita Patel and Juehong Wang and Kumiko Shiozawa and Jones, {Kevin B.} and Yanfeng Zhang and Prokop, {Jeremy W.} and Davenport, {George G.} and Nihira, {Naoe T.} and Zhenyue Hao and Derek Wong and Laurel Brandsmeier and Meadows, {Sarah K.} and Sampaio, {Arthur V.} and Werff, {Ryan Vander} and Makoto Endo and Capecchi, {Mario R.} and McNagny, {Kelly M.} and Mak, {Tak W.} and Nielsen, {Torsten O.} and Underhill, {T. Michael} and Myers, {Richard M.} and Tadashi Kondo and Le Su",
year = "2019",
month = "3",
day = "29",
doi = "10.1016/j.isci.2019.02.008",
language = "English",
volume = "13",
pages = "43--54",
journal = "iScience",
issn = "2589-0042",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor Suppression

AU - Patel, Nikita

AU - Wang, Juehong

AU - Shiozawa, Kumiko

AU - Jones, Kevin B.

AU - Zhang, Yanfeng

AU - Prokop, Jeremy W.

AU - Davenport, George G.

AU - Nihira, Naoe T.

AU - Hao, Zhenyue

AU - Wong, Derek

AU - Brandsmeier, Laurel

AU - Meadows, Sarah K.

AU - Sampaio, Arthur V.

AU - Werff, Ryan Vander

AU - Endo, Makoto

AU - Capecchi, Mario R.

AU - McNagny, Kelly M.

AU - Mak, Tak W.

AU - Nielsen, Torsten O.

AU - Underhill, T. Michael

AU - Myers, Richard M.

AU - Kondo, Tadashi

AU - Su, Le

PY - 2019/3/29

Y1 - 2019/3/29

N2 - Histone deacetylases (HDACs)are promising targets for cancer therapy, although their individual actions remain incompletely understood. Here, we identify a role for HDAC2 in the regulation of MDM2 acetylation at previously uncharacterized lysines. Upon inactivation of HDAC2, this acetylation creates a structural signal in the lysine-rich domain of MDM2 to prevent the recognition and degradation of its downstream substrate, MCL-1 ubiquitin ligase E3 (MULE). This mechanism further reveals a therapeutic connection between the MULE ubiquitin ligase function and tumor suppression. Specifically, we show that HDAC inhibitor treatment promotes the accumulation of MULE, which diminishes the t(X; 18)translocation-associated synovial sarcomagenesis by directly targeting the fusion product SS18-SSX for degradation. These results uncover a new HDAC2-dependent pathway that integrates reversible acetylation signaling to the anticancer ubiquitin response.

AB - Histone deacetylases (HDACs)are promising targets for cancer therapy, although their individual actions remain incompletely understood. Here, we identify a role for HDAC2 in the regulation of MDM2 acetylation at previously uncharacterized lysines. Upon inactivation of HDAC2, this acetylation creates a structural signal in the lysine-rich domain of MDM2 to prevent the recognition and degradation of its downstream substrate, MCL-1 ubiquitin ligase E3 (MULE). This mechanism further reveals a therapeutic connection between the MULE ubiquitin ligase function and tumor suppression. Specifically, we show that HDAC inhibitor treatment promotes the accumulation of MULE, which diminishes the t(X; 18)translocation-associated synovial sarcomagenesis by directly targeting the fusion product SS18-SSX for degradation. These results uncover a new HDAC2-dependent pathway that integrates reversible acetylation signaling to the anticancer ubiquitin response.

UR - http://www.scopus.com/inward/record.url?scp=85066243711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066243711&partnerID=8YFLogxK

U2 - 10.1016/j.isci.2019.02.008

DO - 10.1016/j.isci.2019.02.008

M3 - Article

AN - SCOPUS:85066243711

VL - 13

SP - 43

EP - 54

JO - iScience

JF - iScience

SN - 2589-0042

ER -